Ardent Health, Inc.
ARDTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Ardent Health, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 4 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 8, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| STRS OHIO | 2026-03-31 | 59,600 | $510K | SEC filing |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 2026-03-31 | 930,668 | $7.97M | SEC filing |
| PRELUDE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 20,620 | $177K | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 724 | $6.2K | SEC filing |
| ALGERT GLOBAL LLC | 2026-03-31 | 43,400 | Not shown | SEC filing |
| DENALI ADVISORS LLC | 2026-03-31 | 249,450 | $2.14M | SEC filing |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2026-03-31 | 1,151 | $9.85K | SEC filing |
| CastleKnight Management LP | 2026-03-31 | 1,076,967 | $9.22M | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 8,737 | $74.8K | SEC filing |
| Swiss National Bank | 2026-03-31 | 55,500 | $475K | SEC filing |
| CHAI TRUST CO LLC | 2026-03-31 | 77,246,499 | $661M | SEC filing |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2026-03-31 | 10,400 | $89K | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2026-03-31 | 235 | $2.01K | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 71,900 | $615K | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 14,030 | $120K | SEC filing |
| FIFTH THIRD BANCORP | 2026-03-31 | 21,674 | $186K | SEC filing |
| Capital Advisors, Ltd. LLC | 2026-03-31 | 480 | Not shown | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 36,749 | Not shown | SEC filing |
| MARTINGALE ASSET MANAGEMENT L P | 2026-03-31 | 28,672 | $245K | SEC filing |
| GOLDENTREE ASSET MANAGEMENT LP | 2026-03-31 | 2,303,113 | $19.7M | SEC filing |
- Each value is checked against Ardent Health, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 3 rows: the filed value is about 1,000 times too small for the share count at Ardent Health, Inc.'s share price.
120 filers have only one report here.
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-05 | LUMSDAINE ALFRED · Chief Financial Officer | Common Stock | P — Open market or private purchase | +10,000 | 8.81 | SEC filing |
| 2026-06-05 | DeMichiei Robert · Director | Common Stock | P — Open market or private purchase | +11,260 | 8.73 | SEC filing |
| 2024-11-08 | Webb Robert Thomas · Director | Common Stock | P — Open market or private purchase | +10,000 | 17.47 | SEC filing |
| 2024-11-08 | Webb Robert Thomas · Director | Common Stock | P — Open market or private purchase | +10,000 | 16.49 | SEC filing |
Showing 4 of 4 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-01 | Havdala Ellen · Director | Common Stock | A — Grant, award, or other acquisition | +14,231 | SEC filing |
| 2026-04-01 | Campion Suzanne · Director | Common Stock | A — Grant, award, or other acquisition | +14,231 | SEC filing |
| 2026-04-01 | LUMSDAINE ALFRED · Chief Financial Officer | Common Stock | A — Grant, award, or other acquisition | +53,846 | SEC filing |
| 2026-04-01 | Bonick Martin · President and CEO | Common Stock | A — Grant, award, or other acquisition | +134,615 | SEC filing |
| 2026-04-01 | Caspers Dave · Chief Operating Officer | Common Stock | A — Grant, award, or other acquisition | +35,673 | SEC filing |
| 2026-04-01 | Bulgarelli Peter J. · Director | Common Stock | A — Grant, award, or other acquisition | +14,231 | SEC filing |
| 2026-04-01 | Byers David Raynor · SVP & Chief Accounting Officer | Common Stock | A — Grant, award, or other acquisition | +11,538 | SEC filing |
| 2026-04-01 | Sen Rahul · Director | Common Stock | A — Grant, award, or other acquisition | +14,231 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.